| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |